Antıbody to Adalımumab ELISA

Enzyme immunoassay for the quantitative and qualitative determination of free antibodies to Adalimumab (Humira®) in serum and plasma.

The solid phase (MTP) is coated by the drug Adalimumab. Due to the assay design this test measures the free antibodies which are not bound to Adalimumab. Results could be expressed in both qualitative and quantitative manner (nanogram per mililiter-ng/mL).

Reference: IG-BB103

Barcode: 8682754930110

Legal Status: CE-Mark

Intended Use: This kit has been developed for the detection of anti-drug antibodies in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

Related Documents

Quality Control Certificates

CoA BB103-209 

Humira® is trademark of Abbott Laboratories.


Required Volume (µL) 50
Incubation Time (min) 135
Sample Serum, Plasma
Package Size 96
Results in Qualitative & Quantitative (ng/mL)
Shelf Life (years) 2